Article (Faculty180)

• 2023

  Parathyroid Hormone-Related Protein/Parathyroid Hormone Receptor 1 Signaling in Cancer and Metastasis.  Cancers.  15.
• 2022

  Enzalutamide-induced and PTH1R-mediated TGFBR2 degradation in osteoblasts confers resistance in prostate cancer bone metastases.  Cancer letters.  525:170-178.
• 2022

  Therapeutic Activity of the Lansoprazole Metabolite 5-Hydroxy Lansoprazole Sulfide in Triple-Negative Breast Cancer by Inhibiting the Enoyl Reductase of Fatty Acid Synthase.  Journal of medicinal chemistry.  65:13681-13691.
• 2021

  Dive into Single, Seek Out Multiple: Probing Cancer Metastases via Single-Cell Sequencing and Imaging Techniques.  Cancers.  13.
• 2020

  Notch3 promotes prostate cancer-induced bone lesion development via MMP-3.  Oncogene.  39:204-218.
• 2018

  Loss of Myeloid-Specific TGF-β Signaling Decreases CTHRC1 to Downregulate bFGF and the Development of H1993-Induced Osteolytic Bone Lesions.  Cancers.  10.
• 2018

  Loss of TGF-β signaling in osteoblasts increases basic-FGF and promotes prostate cancer bone metastasis.  Cancer letters.  418:109-118.
• 2018

  Mechanisms and Approaches for Overcoming Enzalutamide Resistance in Prostate Cancer.  Frontiers in oncology.  8:180.
• 2018

  TGF-β receptors: In and beyond TGF-β signaling.  Cellular signalling.  52:112-120.
• 2017

  MYC Mediates Large Oncosome-Induced Fibroblast Reprogramming in Prostate Cancer.  Cancer research.  77:2306-2317.
• 2016

  Molecular Mechanisms of Therapies for Prostate Cancer with Bone Metastasis.  Journal of Exploratory Research in Pharmacology. 
• 2016

  Myeloid-specific TGF-β signaling in bone promotes basic-FGF and breast cancer bone metastasis.  Oncogene.  35:2370-8.
• 2014

  A reciprocal role of prostate cancer on stromal DNA damage.  Oncogene.  33:4924-31.
• 2014

  The host microenvironment influences prostate cancer invasion, systemic spread, bone colonization, and osteoblastic metastasis.  Frontiers in oncology.  4:364.
• 2012

  Loss of TGF-β responsiveness in prostate stromal cells alters chemokine levels and facilitates the development of mixed osteoblastic/osteolytic bone lesions.  Molecular cancer research : MCR.  10:494-503.
• 2011

  Epithelial Hic-5/ARA55 expression contributes to prostate tumorigenesis and castrate responsiveness.  Oncogene.  30:167-77.
• 2011

  Role for stromal heterogeneity in prostate tumorigenesis.  Cancer research.  71:3459-70.
• 2011

  Yes-associated protein expression in head and neck squamous cell carcinoma nodal metastasis.  PloS one.  6:e27529.
• 2010

  Bone marrow derived mesenchymal stem cells incorporate into the prostate during regrowth.  PloS one.  5:e12920.
• 2009

  Urothelial transdifferentiation to prostate epithelia is mediated by paracrine TGF-beta signaling.  Differentiation; research in biological diversity.  77:95-102.
• 2008

  Prostate tumor progression is mediated by a paracrine TGF-beta/Wnt3a signaling axis.  Oncogene.  27:7118-30.
• 2008

  Stromal transforming growth factor-beta signaling mediates prostatic response to androgen ablation by paracrine Wnt activity.  Cancer research.  68:4709-18.
• 2004

  Estrogen directly induces expression of retinoic acid biosynthetic enzymes, compartmentalized between the epithelium and underlying stromal cells in rat uterus.  Endocrinology.  145:4756-62.
• 2003

  Cellular retinoic acid-binding protein II gene expression is directly induced by estrogen, but not retinoic acid, in rat uterus.  The Journal of biological chemistry.  278:35819-25.
• 2002

  Divergent effects of retinoic acids on the expression of ERalpha and 17beta-hydroxysteroid dehydrogenase type 2 in endometrial carcinoma cells (RL 95-2).  The Journal of clinical endocrinology and metabolism.  87:640-9.
• 2002

  Transforming growth factorβ1 and epidermal growth factor decrease the expression of 17β-hydroxysteroid dehydrogenase type 2 in endometrial carcinoma cells.  Springer Link.